Matches in SemOpenAlex for { <https://semopenalex.org/work/W2567095994> ?p ?o ?g. }
- W2567095994 endingPage "1234" @default.
- W2567095994 startingPage "1221" @default.
- W2567095994 abstract "Background Clinically relevant postoperative pancreatic fistula (grades B and C of the ISGPS definition) remains the most troublesome complication after pancreatoduodenectomy. The approach to management of the pancreatic remnant via some form of pancreatico-enteric anastomosis determines the incidence and severity of clinically relevant postoperative pancreatic fistula. Despite numerous trials comparing diverse pancreatico-enteric anastomosis techniques and other adjunctive strategies (pancreatic duct stenting, somatostatin analogues, etc), currently, there is no clear consensus regarding the ideal method of pancreatico-enteric anastomosis. Methods An international panel of pancreatic surgeons working in well-known, high-volume centers reviewed the best contemporary literature concerning pancreatico-enteric anastomosis and worked to develop a position statement on pancreatic anastomosis after pancreatoduodenectomy. Results There is inherent risk assumed by creating a pancreatico-enteric anastomosis based on factors related to the gland (eg, parenchymal texture, disease pathology). None of the technical variations of pancreaticojejunal or pancreaticogastric anastomosis, such as duct-mucosa, invagination method, and binding technique, have been found to be consistently superior to another. Randomized trials and meta-analyses comparing pancreaticogastrostomy versus pancreaticojejunostomy yield conflicting results and are inherently prone to bias due to marked heterogeneity in the studies. The benefit of stenting the pancreatico-enteric anastomosis to decrease clinically relevant postoperative pancreatic fistula is not supported by high-level evidence. While controversial, somatostatin analogues appear to decrease perioperative complications but not mortality, although consistent data across the more than 20 studies addressing this topic are lacking. The Fistula Risk Score is useful for predicting postoperative pancreatic fistula as well as for comparing outcomes of pancreatico-enteric anastomosis across studies. Conclusion Currently, no specific technique can eliminate development of clinically relevant postoperative pancreatic fistula. While consistent practice of any standardized technique may decrease the rate of clinically relevant postoperative pancreatic fistula, experienced surgeons can have lower postoperative pancreatic fistula rates performing a variety of techniques depending on the clinical situation. There is no clear evidence on the benefit of internal or external stenting after pancreatico-enteric anastomosis. The use of somatostatin analogues may be important in decreasing morbidity after pancreatoduodenectomy, but it remains controversial. Future studies should focus on novel approaches to decrease the rate of clinically relevant postoperative pancreatic fistula with appropriate risk adjustment. Clinically relevant postoperative pancreatic fistula (grades B and C of the ISGPS definition) remains the most troublesome complication after pancreatoduodenectomy. The approach to management of the pancreatic remnant via some form of pancreatico-enteric anastomosis determines the incidence and severity of clinically relevant postoperative pancreatic fistula. Despite numerous trials comparing diverse pancreatico-enteric anastomosis techniques and other adjunctive strategies (pancreatic duct stenting, somatostatin analogues, etc), currently, there is no clear consensus regarding the ideal method of pancreatico-enteric anastomosis. An international panel of pancreatic surgeons working in well-known, high-volume centers reviewed the best contemporary literature concerning pancreatico-enteric anastomosis and worked to develop a position statement on pancreatic anastomosis after pancreatoduodenectomy. There is inherent risk assumed by creating a pancreatico-enteric anastomosis based on factors related to the gland (eg, parenchymal texture, disease pathology). None of the technical variations of pancreaticojejunal or pancreaticogastric anastomosis, such as duct-mucosa, invagination method, and binding technique, have been found to be consistently superior to another. Randomized trials and meta-analyses comparing pancreaticogastrostomy versus pancreaticojejunostomy yield conflicting results and are inherently prone to bias due to marked heterogeneity in the studies. The benefit of stenting the pancreatico-enteric anastomosis to decrease clinically relevant postoperative pancreatic fistula is not supported by high-level evidence. While controversial, somatostatin analogues appear to decrease perioperative complications but not mortality, although consistent data across the more than 20 studies addressing this topic are lacking. The Fistula Risk Score is useful for predicting postoperative pancreatic fistula as well as for comparing outcomes of pancreatico-enteric anastomosis across studies. Currently, no specific technique can eliminate development of clinically relevant postoperative pancreatic fistula. While consistent practice of any standardized technique may decrease the rate of clinically relevant postoperative pancreatic fistula, experienced surgeons can have lower postoperative pancreatic fistula rates performing a variety of techniques depending on the clinical situation. There is no clear evidence on the benefit of internal or external stenting after pancreatico-enteric anastomosis. The use of somatostatin analogues may be important in decreasing morbidity after pancreatoduodenectomy, but it remains controversial. Future studies should focus on novel approaches to decrease the rate of clinically relevant postoperative pancreatic fistula with appropriate risk adjustment." @default.
- W2567095994 created "2017-01-06" @default.
- W2567095994 creator A5000483058 @default.
- W2567095994 creator A5008060437 @default.
- W2567095994 creator A5010327766 @default.
- W2567095994 creator A5011077706 @default.
- W2567095994 creator A5015416945 @default.
- W2567095994 creator A5016687244 @default.
- W2567095994 creator A5017131490 @default.
- W2567095994 creator A5022252196 @default.
- W2567095994 creator A5023596163 @default.
- W2567095994 creator A5025415933 @default.
- W2567095994 creator A5035290802 @default.
- W2567095994 creator A5036032282 @default.
- W2567095994 creator A5036258878 @default.
- W2567095994 creator A5039983309 @default.
- W2567095994 creator A5046624072 @default.
- W2567095994 creator A5048162509 @default.
- W2567095994 creator A5051782291 @default.
- W2567095994 creator A5052619250 @default.
- W2567095994 creator A5052825850 @default.
- W2567095994 creator A5060021577 @default.
- W2567095994 creator A5060706812 @default.
- W2567095994 creator A5066966766 @default.
- W2567095994 creator A5071291870 @default.
- W2567095994 creator A5071927479 @default.
- W2567095994 creator A5074748035 @default.
- W2567095994 creator A5081205674 @default.
- W2567095994 creator A5081306432 @default.
- W2567095994 creator A5087716350 @default.
- W2567095994 creator A5089608755 @default.
- W2567095994 date "2017-05-01" @default.
- W2567095994 modified "2023-10-14" @default.
- W2567095994 title "Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS)" @default.
- W2567095994 cites W1588409322 @default.
- W2567095994 cites W1808854996 @default.
- W2567095994 cites W1924151685 @default.
- W2567095994 cites W1934066837 @default.
- W2567095994 cites W1954216426 @default.
- W2567095994 cites W1965715035 @default.
- W2567095994 cites W1967023649 @default.
- W2567095994 cites W1968739291 @default.
- W2567095994 cites W1980543978 @default.
- W2567095994 cites W1981469806 @default.
- W2567095994 cites W1982281346 @default.
- W2567095994 cites W1984515135 @default.
- W2567095994 cites W1986284221 @default.
- W2567095994 cites W1986409342 @default.
- W2567095994 cites W1995176709 @default.
- W2567095994 cites W1997032414 @default.
- W2567095994 cites W1997721854 @default.
- W2567095994 cites W2002867523 @default.
- W2567095994 cites W2006977914 @default.
- W2567095994 cites W2008110338 @default.
- W2567095994 cites W2011158851 @default.
- W2567095994 cites W2011874830 @default.
- W2567095994 cites W2015951555 @default.
- W2567095994 cites W2021699594 @default.
- W2567095994 cites W2021925934 @default.
- W2567095994 cites W2028636108 @default.
- W2567095994 cites W2029617523 @default.
- W2567095994 cites W2031407665 @default.
- W2567095994 cites W2031596762 @default.
- W2567095994 cites W2032622218 @default.
- W2567095994 cites W2035476720 @default.
- W2567095994 cites W2039608766 @default.
- W2567095994 cites W2048134905 @default.
- W2567095994 cites W2050010050 @default.
- W2567095994 cites W2050967082 @default.
- W2567095994 cites W2051656658 @default.
- W2567095994 cites W2055828871 @default.
- W2567095994 cites W2059382330 @default.
- W2567095994 cites W2060834665 @default.
- W2567095994 cites W2061135644 @default.
- W2567095994 cites W2066266237 @default.
- W2567095994 cites W2066432149 @default.
- W2567095994 cites W2066489189 @default.
- W2567095994 cites W2068059909 @default.
- W2567095994 cites W2071705318 @default.
- W2567095994 cites W2075591824 @default.
- W2567095994 cites W2076838722 @default.
- W2567095994 cites W2077325866 @default.
- W2567095994 cites W2082697796 @default.
- W2567095994 cites W2082853579 @default.
- W2567095994 cites W2084372896 @default.
- W2567095994 cites W2086045434 @default.
- W2567095994 cites W2089363491 @default.
- W2567095994 cites W2090401649 @default.
- W2567095994 cites W2094631589 @default.
- W2567095994 cites W2096074908 @default.
- W2567095994 cites W2097665416 @default.
- W2567095994 cites W2103890846 @default.
- W2567095994 cites W2105382366 @default.
- W2567095994 cites W2108443032 @default.
- W2567095994 cites W2116139289 @default.
- W2567095994 cites W2116431124 @default.
- W2567095994 cites W2117853299 @default.
- W2567095994 cites W2131254562 @default.